Concepedia

Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease

Jeffrey S. Hyams, Marla C. Dubinsky, Robert N. Baldassano, Richard B. Colletti, Salvatore Cucchiara, Johanna C. Escher, William A. Faubion, John Fell, Benjamin D. Gold, Anne M. Griffiths,

Gastroenterology · 2017 · 216 citations · 27 references

DOI

Concepts

References

27

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

Laurent Beaugerie, Nicole Brousse, Anne‐Marie Bouvier et al. · The Lancet · 2009 · 1.1K citations

, , +11

Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

James D. Lewis, Shaokun Chuai, Lisa Nessel et al. · Inflammatory Bowel Diseases · 2008 · 952 citations · Full text

, , +17

Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children

Jeffrey S. Hyams, Wallace Crandall, Subra Kugathasan et al. · Gastroenterology · 2006 · 870 citations · Full text

, , +12

Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease

Millie D. Long, Christopher F. Martin, Clare A. Pipkin et al. · Gastroenterology · 2012 · 521 citations · Full text

, , +14

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

Laurent Peyrin‐Biroulet, Kiarash Khosrotehrani, Fabrice Carrat et al. · Gastroenterology · 2011 · 488 citations · Full text

, , +16